Nikita V. Enenkov

Nikita V. Enenkov

Auto-generated profile, based on publicly available information

Nikita V. Enenkov

Рязанский государственный медицинский университет им. академика И. П. Павлова

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 August 2025 in Pharmacokinetics and Pharmacodynamics
Verified
Journal Article
Open access
PDF file
SSSergey Vladmirovich Seleznev
Sergey Vladmirovich Seleznev
ASAleksey Shchulkin
Aleksey Shchulkin
PMP. Yu. Mylnikov
P. Yu. Mylnikov
NEN. V. Enenkov
N. V. Enenkov
Background. Metoprolol is a selective beta-blocker that is most commonly used in the pharmacotherapy of cardiovascular diseases, including hypertension (AH).Objective. To evaluate the pharmacokinetics of metoprolol tartrate in patients with controlled and uncontrolled AH.Materials and methods. An open cohort study was conducted at the Hospital Therapy Department of the Ryazan State Medical University in the Ryazan Regional Clinical Cardiology Dispensary. The study included 45 patients, including 29 with uncontrolled AH and 15 with controlled AH. All patients regularly take any two antihypertensive drugs (AHD) (lisinopril, amlodipine, and metoprolol tartrate) along with indapamide for a month. In the morning before and 2 h after taking metoprolol, venous blood samples were collected to assess the concentration of the analyzed substance (C0h and C2h, respectively) using high-performance liquid chromatography with tandem mass spectrometry.Results. Analysis of C0h and C2h of metoprolol tartrate did not show statistically significant differences in patients with controlled and uncontrolled AH. In 93 % of patients, C0h and in 57.8 %, C2h were below the lower limit of the therapeutic range, without statistically significant differences in controlled and uncontrolled AH. The median daily dose of metoprolol tartrate was 50 (25; 75) mg, which is insufficient according to the AH guidelines (the recommended dose is 100 mg).Conclusion. Thus, the pharmacokinetics of metoprolol tartrate did not make a significant contribution to achieving blood pressure control. In most cases, metoprolol tartrate concentration is below the therapeutic range, which is associated with a low drug dose.

1 November 2023 in Voprosy onkologii
Verified
Journal Article
Open access
МММаксим Валерьевич Мнихович
Максим Валерьевич Мнихович
НЕНикита Васильевич Ененков
Никита Васильевич Ененков
ЛЕЛюдмила Михайловна Ерофеева
Людмила Михайловна Ерофеева
TBTatiana Vasilievna Bezuglova
Tatiana Vasilievna Bezuglova
ИШИван Александрович Ширипенко
Иван Александрович Ширипенко
Accessory breasts develop because of partial regression of embryonic mammary lines not only in women but also in men and are predominantly located in the axillary region. These glands may not have external manifestations (the presence of a nipple and areola). They manifest symptomatically with cyclic pain and oedema during menstruation and pregnancy, due to hormonal changes. Accessory breast can undergo both benign and malignant pathological changes, just like normal anatomical mammary glands. Due to the low prevalence of accessory breasts (in 2-6% of women) and their pathological changes, most of the global literature includes descriptions of individual clinical cases. Therefore, the aim of this review is to examine the structure, normal morphogenesis, and pathological changes of accessory breasts. In preparation for this review, we conducted a comprehensive literature search using databases such as Scopus, Web of Science, Medline, PubMed, CyberLeninka, RINC, and CNKI. We analyzed both domestic and international scientific and clinical studies indexed in Scopus, Web of Science, and PubMed, with 31 % of these studies being published within the last 5 years. In total, we referenced 72 sources for the composition of this literature review. Дополнительные молочные железы развиваются в результате неполной регрессии эмбриональных молочных линий не только у женщин, но и у мужчин, располагаются преимущественно в подмышечной впадине. Эти железы могут не иметь внешних проявлений (наличие соска и ареолы). Симптоматически проявляются циклическими болями и отеком во время менструации и беременности, обусловленными гормональными перестройками. Дополнительные молочные железы могут претерпевать и доброкачественные, и злокачественные патологические изменения, также как обычные анатомические молочные железы. В связи с низкой частотой встречаемости дополнительной молочной железы (у 2–6 % женщин) и ее патологических изменений, большая часть мировой литературы включает описания отдельных клинических случаев. Поэтому цель настоящего обзора: рассмотреть структуру, нормальный морфогенез и патологические изменения дополнительной молочной железы. Для подготовки обзора проведен поиск литературы по базам данных Scopus, Web of Science, Medline, PubMed, CyberLeninka, РИНЦ и CNKI. При анализе использованы отечественные и зарубежные научные и клинические исследования, индексируемые в базах данных Scopus, Web of Science, PubMed, из них 31 % опубликованны за последние 5 лет. Использовано 72 источника для написания данного литературного обзора.

28 March 2026 in Yakut Medical Journal
Verified
Journal Article
Open access
PDF file
NEN. V. Enenkov
N. V. Enenkov
AEA. O. Enenkova
A. O. Enenkova
GYGrigoriy Yakubovskiy
Grigoriy Yakubovskiy
Hereditary hemorrhagic telangiectasia (Osler-Rendu-Weber disease) is a rare disorder with an autosomal dominant inheritance pattern, characterized by small arteriovenous malformations (AVMs) on the mucous membranes and skin (telangiectasias), as well as larger visceral AVMs in the lungs, liver, and brain. This article presents a clinical case of Osler-Rendu-Weber disease affecting the respiratory system and brain in a 45-year-old female patient. A diagnostic algorithm for suspected hereditary hemorrhagic telangiectasia is also proposed.

30 December 2025 in Yakut Medical Journal
Verified
Journal Article
Closed access
EBE. E. Blokhova
E. E. Blokhova
RGR. A. Gudkov
R. A. Gudkov
ADA. V. Dmitriev
A. V. Dmitriev
NEN. V. Enenkov
N. V. Enenkov
ASA. O. Slavova
A. O. Slavova
The article describes a clinical case of Kartagener syndrome in a 12-year-old patient. During the physical examination, changes in the fingers of the hands of the "drumstick" type and nail plates of the "watch glass" type were recorded. A decrease in spirometry indicators, dextrocardia, chronic bronchitis changes in the lungs were revealed. The number of points on the PICADAR scale is 13. The set of clinical, laboratory and instrumental data, assessment on the PICADAR scale, allowed to establish the diagnosis of primary ciliary dyskinesia: Kartagener syndrome. The presented clinical case clearly demonstrates the problems of differential diagnosis of Kartagener syndrome. Increasing the alertness and awareness of doctors about this disease can help in rapid diagnosis, timely treatment and improving the quality of life of such patients.

21 June 2026 in Yakut Medical Journal
Verified
Journal Article
Open access
PDF file
NEN. V. Enenkov
N. V. Enenkov
SSSergey Vladmirovich Seleznev
Sergey Vladmirovich Seleznev
OEO. V. Evsina
O. V. Evsina
The article describes a clinical case of functional mitral regurgitation in a 76-year-old patient. Upon hospitalization, an echocardiography was performed on an emergency basis, which visualized a violation of the coaptation of the mitral valve flaps, regurgitation of 3-4 degrees on the mitral valve. In this regard, a differential diagnosis of the cause of mitral regurgitation was performed: between the separation of the chords of the mitral valve and functional regurgitation. After angioplasty and stenting of the infarct-related artery, a decrease in the degree of mitral regurgitation was observed on the 7th day of hospitalization, which confirms the effectiveness of treatment and the functional nature of the developed condition. The presented clinical case clearly demonstrates the problems of differential diagnosis of ischemic mitral regurgitation. Increasing doctors' alertness and awareness of functional mitral regurgitation can help in choosing treatment tactics and determining indications for surgery.

30 June 2023 in Nauka Molodykh (Eruditio Juvenium)
Verified
Journal Article
Closed access
TCTat’yana M. Cherdantseva
Tat’yana M. Cherdantseva
RURyazan State Medical University
Ryazan State Medical University
MNMarina S. Nekrasova
Marina S. Nekrasova
AKAntonina A. Kachkurkina
Antonina A. Kachkurkina
NENikita V. Enenkov
Nikita V. Enenkov
AUAltay State Medical University
Altay State Medical University